Revenue

As EverQuote prepares its Q2 2026 report, the market watches closely. Will its AI-powered growth engine justify its ambitious vision for the P&C sector?

As Applied Digital prepares its year-end report, all eyes are on the data center builder. Can it sustain its explosive growth and justify its massive bets on AI?

The firm reported a Q4 loss but a record $111M backlog fuels its ambitious plan for $150M revenue and a pivot to high-growth quantum and defense markets.

Parse Biosciences, QIAGEN's strategic acquisition, just partnered with Australia's Garvan Institute. It's more than science—it's a calculated play to win.

Once a nanotech firm, then a supplement seller, Bioforce Nanosciences is now an oil explorer. Its new 20,000-acre Nevada lease is a high-stakes gamble to reverse a history of financial peril.

SBC Medical is stepping onto the investor stage. We break down their strategy to dominate the booming wellness market, from US expansion to AI-driven healthcare.

Plumas Bancorp's record earnings are fueled by a major acquisition, but a spike in nonperforming assets reveals the inherent risks of rapid expansion.

Cypriot banktech Xryma Plc is listing on Euronext Paris without raising a cent. We explore the strategy behind this unconventional move and its deep infrastructure play.

Serial investor Gary Vaynerchuk takes an equity stake in agency Paul Street, signaling a seismic shift in how premium brands approach partnerships.

A multi-billion dollar acquisition reunites a CEO with his roots. This is no nostalgia play; it's a calculated move to dominate a changing industry.

After a 90% stock crash since its IPO, activist firm Randian Capital is demanding a strategic review, questioning leadership and industry headwinds.

Facing a cash crunch and delisting threat, ENvue Medical stacks its board with clinical, AI, and finance heavyweights. Is it a lifeline or a last-ditch effort?

Entegris's latest dividend is more than a payout; it's a signal of deep financial health and strategic positioning in the critical semiconductor industry.

Vulcan Materials' upcoming earnings are more than numbers. They're a critical signal for the US economy, revealing the real story behind infrastructure and AI.

A new survey shows a fractured industrial landscape. While some sectors thrive, many face a quiet crisis of tariffs and costs, forcing a turn to data and discipline.

Conagra Brands slashed its dividend by 50%, calling it a 'reset.' We dissect if this is a prudent move to fund growth or a red flag for investors.

BNY's stellar Q2 earnings are more than just numbers. They reveal a strategic pivot to a platform model, AI, and digital assets, setting a new bar.

Rubico Inc. is selling its luxury megayacht to double down on oil tankers. A look at whether this strategic pivot can overcome a history of investor doubt.

Gausium is now the world's #1 cleaning robot supplier. This isn't just about automation; it's a strategic blueprint for scalable, intelligent operations.

Amid market volatility, Hunting PLC's H1 results reveal a successful pivot to high-growth subsea and tech, but can this momentum offset legacy segment lags?